SBIR/STTR Research Award

SBIR Phase I: Drug Discovery meets Moore's Law: Synthesizing DNA-Encoded Libraries with Electronics

Award identifier 2bd7891682bd9eed029b8a9363a69a5beda7102c3d242985e08e663420030cb8Awarding agency National Science Foundation

Award amount

$274,932

Program and phase

SBIR · Phase I

Award year

2025

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
National Science Foundation
Branch
Not reported
Recipient company
FEMTOFLUIDICS INCORPORATED
Proposal award date
2024-12-03
Contract end date
2025-08-31
UEI
P1BCQQFLAJP1
Solicitation number
NSF 23-515
Topic code
BT

Research abstract

The broader impact of this Small Business Innovation Research (SBIR) Phase I project is to accelerate drug discovery. Despite massive investment, the pace of drug development is slow and appears to be slowing further, with new drugs taking an average of 15 years from discovery to market approval. This project aims to develop hardware that will permit the rapid and inexpensive synthesis of DNA-encoded libraries (DELs). This will not only expedite finding drugs for challenging diseases but also generate valuable data for training artificial intelligence (AI) models to improve drug prediction. Commercially, this technology will strengthen U.S. competitiveness in drug discovery and reinforce its leadership in automation and AI research. It could also aid in biodefense, enabling faster responses to emerging biological and chemical threats. The proposed project straddles three different disciplines – electronics, chemistry, and material science – requiring specialized knowledge and expertise in each. Electronics have come to dominate our world as an information processing technology. Its function is to manipulate voltage values, representing the 1's and 0's encoding data. This project proposes a means of chemical processing with electronics. The goal is to build a device that can perform combinatorial chemistry on nanoliter to picoliter volume droplets, on an electronic substrate. This will be applied to the task of synthesizing DELs. Unlike liquid-handling robots, the technology has no moving or mechanical parts. Instead, it manipulates droplets with electric charge. Software controls the switching of the voltages on a grid of electrodes, dispensing, moving, splitting, merging, and mixing droplets. The research addresses key technical challenges, including the durability of dielectric and hydrophobic materials, and optimizing electric field control. The chemical protocols for synthesizing DELs will be adapted to novel physical and chemical constraints, inclu

Technology keywords

Not reported

Agency intelligence

National Science Foundation

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.